1. Home
  2. AXR vs ALDX Comparison

AXR vs ALDX Comparison

Compare AXR & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMREP Corporation

AXR

AMREP Corporation

N/A

Current Price

$22.91

Market Cap

132.0M

Sector

Real Estate

ML Signal

N/A

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

N/A

Current Price

$1.48

Market Cap

124.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AXR
ALDX
Founded
1961
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.0M
124.9M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
AXR
ALDX
Price
$22.91
$1.48
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$30.00
$5.50
AVG Volume (30 Days)
9.5K
715.8K
Earning Date
03-12-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
40.43
EPS
1.91
N/A
Revenue
$12,831,000.00
N/A
Revenue This Year
$10.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$1.07
52 Week High
$29.01
$5.93

Technical Indicators

Market Signals
Indicator
AXR
ALDX
Relative Strength Index (RSI) 46.51 39.35
Support Level $21.68 $1.07
Resistance Level $23.52 $1.60
Average True Range (ATR) 0.46 0.07
MACD 0.10 0.01
Stochastic Oscillator 60.50 10.34

Price Performance

Historical Comparison
AXR
ALDX

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: